Skip to Content

Buprenorphine Sublingual Tablets

Last Updated: September 17, 2015
Status: Resolved

Products Affected - Description

Buprenorphine sublingual tablets, Teva
2 mg, 30 count (NDC 00093-5378-56)
8 mg, 30 count (NDC 00093-5379-56)

Reason for the Shortage

  • Teva could not provide a reason for the shortage.
  • Akorn acquired Hi-Tech Pharmacal in 2014.

Available Products

Buprenorphine sublingual tablets, Akorn
2 mg, 30 count (NDC 50383-0930-93)

8 mg, 30 count (NDC 50383-0924-93)

Buprenorphine sublingual tablets, Roxane
2 mg, 30 count (NDC 00054-0176-13)
8 mg, 30 count (NDC 00054-0177-13)

Estimated Resupply Dates

  • Teva has buprenorphine 2 mg and 8 mg sublingual tablets temporarily unavailable and the company cannot estimate a release date.
  • Akorn and Roxane have had product available for several months.

Related Shortages

Updated

September 17, July 14, April 13, January 23, 2015; December 1 and 22, November 4 and 21, September 11, July 9 and 30, May 5, March 3 and 5, January 8, 2014; December 4, November 5, September 23, August 6, July 2, June 18, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide